Bayer Accelerates Cell and Gene Therapy Drive with Atara Deal

Bayer Accelerates Cell and Gene Therapy Drive with Atara Deal Bayer AG has struck a deal with Atara Biotherapeutics to jointly work on Atara’s CAR-T cell anti-tumour treatments, as the German group firms up its commitment to build a specialist cell and gene therapy development platform. Read more...

Go to Top